GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Piotroski F-Score

Star Lake Bioscience Co (SHSE:600866) Piotroski F-Score : 6 (As of May. 01, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Star Lake Bioscience Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Star Lake Bioscience Co's Piotroski F-Score or its related term are showing as below:

SHSE:600866' s Piotroski F-Score Range Over the Past 10 Years
Min: 3   Med: 5   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Star Lake Bioscience Co was 9. The lowest was 3. And the median was 5.


Star Lake Bioscience Co Piotroski F-Score Historical Data

The historical data trend for Star Lake Bioscience Co's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Piotroski F-Score Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.00 4.00 4.00 4.00 6.00

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.00 4.00 4.00 6.00 6.00

Competitive Comparison of Star Lake Bioscience Co's Piotroski F-Score

For the Biotechnology subindustry, Star Lake Bioscience Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Piotroski F-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar24) TTM:Last Year (Mar23) TTM:
Net Income was 109.646 + 259.231 + 188.553 + 251.484 = ¥809 Mil.
Cash Flow from Operations was 1147.526 + 1259.651 + 299.242 + -194.798 = ¥2,512 Mil.
Revenue was 4103.195 + 4462.202 + 4645.087 + 4199.501 = ¥17,410 Mil.
Gross Profit was 474.031 + 649.495 + 825.091 + 640.67 = ¥2,589 Mil.
Average Total Assets from the begining of this year (Mar23)
to the end of this year (Mar24) was
(16571.514 + 14712.672 + 13742.159 + 14384.586 + 14687.215) / 5 = ¥14819.6292 Mil.
Total Assets at the begining of this year (Mar23) was ¥16,572 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,705 Mil.
Total Current Assets was ¥5,360 Mil.
Total Current Liabilities was ¥4,820 Mil.
Net Income was 226.592 + 90.54 + 108.139 + 120.523 = ¥546 Mil.

Revenue was 4650.356 + 4051.261 + 4614.055 + 4163.244 = ¥17,479 Mil.
Gross Profit was 1015.318 + 558.218 + 693.098 + 492.124 = ¥2,759 Mil.
Average Total Assets from the begining of last year (Mar22)
to the end of last year (Mar23) was
(2401.338 + 2438.475 + 2505.831 + 15999.51 + 16571.514) / 5 = ¥7983.3336 Mil.
Total Assets at the begining of last year (Mar22) was ¥2,401 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,580 Mil.
Total Current Assets was ¥6,666 Mil.
Total Current Liabilities was ¥7,460 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Star Lake Bioscience Co's current Net Income (TTM) was 809. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Star Lake Bioscience Co's current Cash Flow from Operations (TTM) was 2,512. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar23)
=808.914/16571.514
=0.04881352

ROA (Last Year)=Net Income/Total Assets (Mar22)
=545.794/2401.338
=0.22728745

Star Lake Bioscience Co's return on assets of this year was 0.04881352. Star Lake Bioscience Co's return on assets of last year was 0.22728745. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Star Lake Bioscience Co's current Net Income (TTM) was 809. Star Lake Bioscience Co's current Cash Flow from Operations (TTM) was 2,512. ==> 2,512 > 809 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar23 to Mar24
=1705.445/14819.6292
=0.11508014

Gearing (Last Year: Mar23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar22 to Mar23
=1580.477/7983.3336
=0.19797206

Star Lake Bioscience Co's gearing of this year was 0.11508014. Star Lake Bioscience Co's gearing of last year was 0.19797206. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar24)=Total Current Assets/Total Current Liabilities
=5360.463/4819.85
=1.11216386

Current Ratio (Last Year: Mar23)=Total Current Assets/Total Current Liabilities
=6665.545/7460.102
=0.89349248

Star Lake Bioscience Co's current ratio of this year was 1.11216386. Star Lake Bioscience Co's current ratio of last year was 0.89349248. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Star Lake Bioscience Co's number of shares in issue this year was 1661.059. Star Lake Bioscience Co's number of shares in issue last year was 1662.39. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=2589.287/17409.985
=0.14872425

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=2758.758/17478.916
=0.15783347

Star Lake Bioscience Co's gross margin of this year was 0.14872425. Star Lake Bioscience Co's gross margin of last year was 0.15783347. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar23)
=17409.985/16571.514
=1.05059713

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar22)
=17478.916/2401.338
=7.27882372

Star Lake Bioscience Co's asset turnover of this year was 1.05059713. Star Lake Bioscience Co's asset turnover of last year was 7.27882372. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Star Lake Bioscience Co has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Star Lake Bioscience Co  (SHSE:600866) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Star Lake Bioscience Co Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines